Universal vs. ASCO guidelines-based germline genetic testing for newly diagnosed breast cancer patients in resource-restricted settings

BackgroundA significant subset of breast cancer cases is attributable to inherited pathogenic genetic variants. Germline genetic testing (GGT), particularly for BRCA1 and BRCA2, represents a critical tool for precision oncology, enabling individualized risk stratification and the development of tail...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Hikmat Abdel-Razeq, Faris Tamimi, Sarah Abdel-Razeq, Baha Sharaf, Hanan Khalil, Hira Bani Hani, Hala Abu-Jaish, Suhaib Khater, Lulwa El Saket, Tamer Al-Batsh, Marwa Sh Abrahim, Mohammad Sammour, Asem Mansour
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Frontiers Media S.A. 2026-01-01
Σειρά:	Oncology Reviews
Θέματα:	germline genetic testing GGT breast cancer BRCA1 BRCA2 resource-restrictedcountries
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/or.2025.1638255/full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!